tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Myles Minter, 2 are a BUY (100%).
Analyst Myles Minter, currently employed at WILLIAM BLAIR, carries an average stock price target met ratio of 50% that have a potential upside of 11.86% achieved within 4 days.
Myles Minter’s has documented 8 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KRTX, Karuna Therapeutics at 13-Jul-2023.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 1/14/2020. The price target of $105 was fulfilled within 7 days with a profit of $20.13 (23.72%) receiving and performance score of 33.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2.5
$0.64 (34.41%)
$9
9 days ago
(17-Dec-2024)
1/6 (16.67%)
$0.58 (30.21%)
24
Buy
$4
$2.14 (115.05%)
$15
10 days ago
(16-Dec-2024)
1/5 (20%)
$2.06 (106.19%)
128
Hold
$3
$1.14 (61.29%)
$10
1 months ago
(26-Nov-2024)
1/6 (16.67%)
$0.4 (15.38%)
332
Buy
$5
$3.14 (168.82%)
$16
1 months ago
(26-Nov-2024)
1/3 (33.33%)
$2.4 (92.31%)
70
Buy
$35
$33.14 (1781.72%)
$35
1 months 19 days ago
(07-Nov-2024)
0/7 (0%)
$29.36 (520.57%)
What Year was the first public recommendation made by Myles Minter?
